FDA
-
-
-
-
-
-
-
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
-
-
-
-
-
-
-
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
-
-
-
-
-
-
-
Sigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis
-
-
-
-
-
-
-
Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs
-
-
-
-
-
322,978 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

